Jeffrey L. Anderson

A. Tandar, K. G. Meredith, Jeffrey L. Anderson, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Intermittent fasting and changes in Galectin-3: A secondary analysis of a randomized controlled trial of disease-free subjects.

B. Horne, H. May, T. Bair, 2022, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Novel Cardiac Troponin T Mutation as a Cause of Familial Dilated Cardiomyopathy

R. Brugada, M. Quiñones, J. Durand, 2001, Circulation.

TIMI Perfusion Grade 3 but Not Grade 2 Results in Improved Outcome After Thrombolysis for Myocardial Infarction Ventriculographic, Enzymatic, Electrocardiographic Evidence From the TEAM‐3 Study

L. Becker, J. Anderson, S. Sorensen, 1993, Circulation.

Thrombolysis and Myocardial Salvage Results of Clinical Trials and the Animal Paradigm‐ Paradoxic or Predictable?

B. Gersh, Jeffrey L. Anderson, J. Anderson, 1993, Circulation.

Pharmacogenomics in Cardiovascular Medicine

J. Carlquist, Jeffrey L. Anderson, 2004 .

Response to Encainide of Refractory Ventricular Tachycardia: Clinical Application of Assays for Parent Drug and Metabolites

B. Pitt, J. Anderson, J. Stewart, 1982, Journal of Cardiovascular Pharmacology.

An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose prediction

B. Horne, J. Carlquist, J. Muhlestein, 2010, Journal of Thrombosis and Thrombolysis.

Interaction of Baseline Characteristics With The Hazard of Encainide, Flecainide, and Moricizine Therapy in Patients With Myocardial Infarction: A Possible Explanation for Increased Mortality in the Cardiac Arrhythmia Suppression Trial (CAST)

A. Hallstrom, P. Carson, R. Henthorn, 1994, Circulation.

Progress in unraveling the genetics of coronary artery disease and myocardial infarction

B. Horne, J. Carlquist, P. Hopkins, 2007, Current atherosclerosis reports.

Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long‐Term Risk of Dementia

H. May, T. Bair, Jeffrey L. Anderson, 2015, Journal of cardiovascular electrophysiology.

Association of the dispersion in red blood cell volume with mortality

B. Horne, H. May, J. Muhlestein, 2015, European journal of clinical investigation.

Real-world clinical burden and economic assessment associated with hyperkalaemia in a large integrated healthcare system: a retrospective analysis

H. May, D. Lappé, T. Bair, 2021, BMC Primary Care.

Plasma Homocysteine Predicts Mortality Independently of Traditional Risk Factors and C-Reactive Protein in Patients With Angiographically Defined Coronary Artery Disease

B. Horne, J. Carlquist, R. Pearson, 2000, Circulation.

Nonlinear Heart Rate Variability:

B. Horne, Jeffrey L Anderson, Benjamin D Horne, 2005, Journal of cardiovascular electrophysiology.

Validation Study of Genetic Associations with Coronary Artery Disease on Chromosome 3q13‐21 and Potential Effect Modification by Smoking

W. Kraus, B. Horne, J. Carlquist, 2009, Annals of human genetics.

Apolipoprotein Polymorphisms Fail to Define Risk of Coronary Artery Disease: Results of a Prospective, Angiographically Controlled Study

R. Ward, J. Anderson, L. Karagounis, 1994, Circulation.

Association of Rhesus factor blood type with risk of SARS‐CoV‐2 infection and COVID‐19 severity

B. Horne, H. May, T. Bair, 2022, British Journal of Haematology.

2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Jeffrey L. Anderson, J. Cigarroa, M. Mack, 2011, Circulation.

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Jane A. Linderbaum, J. Ornato, M. Chung, 2013, Journal of the American College of Cardiology.

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Harlan M Krumholz, Joseph P Ornato, Faha, 2013, Circulation.

Angiography and Interventions Association Task Force on Practice Guidelines and the Society for Cardiovascular Summary : A Report of the American College of Cardiology Foundation/American Heart 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive

V. Chair, C. Yancy, J. Halperin, 2012 .

ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).

Richard P. Lewis, R. Califf, E. Antman, 1996, Journal of the American College of Cardiology.

Genotype-Based Dosing Algorithms for Warfarin Therapy

B. Horne, J. Carlquist, Jeffrey L. Anderson, 2011, Molecular Diagnosis & Therapy.

Myocardial Infarction Associated with Regional Myocardial Flow Deficit and Normal Coronary Arteries in a Patient with COVID-19: A Case Report

J. Muhlestein, K. Knowlton, Joel E Money, 2020 .

High‐Resolution Characterization of Linkage Disequilibrium Structure and Selection of Tagging Single Nucleotide Polymorphisms: Application to the Cholesteryl Ester Transfer Protein Gene

B. Horne, N. Camp, J. Carlquist, 2006, Annals of human genetics.

Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non‐valvular atrial fibrillation (cognitive decline and dementia in patients with non‐valvular atrial fibrillation [CAF] trial)

H. May, T. Bunch, M. Cutler, 2022, Journal of arrhythmia.

Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study.

B. Horne, J. Carlquist, C. Nielson, 1999, Circulation.

Guidelines for the management of patients with valvular heart disease: executive summary

E. Antman, R. Gibbons, K. Eagle, 1998, Circulation.

ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).

J. Ornato, E. Antman, Jeffrey L. Anderson, 2004, Circulation.

Generating Genetic Risk Scores from Intermediate Phenotypes for Use in Association Studies of Clinically Significant Endpoints

N J Camp, B. Horne, N. Camp, 2005, Annals of human genetics.

A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction.

J. Carlquist, T. Bair, M. Todd, 1997, Journal of the American College of Cardiology.

Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model.

J. Carlquist, J. Muhlestein, E. Hammond, 1998, Circulation.

Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease.

M L Woods, J. Carlquist, J. Muhlestein, 1996, Journal of the American College of Cardiology.

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Jennifer G. Robinson, D. DeMets, R. D'Agostino, 2014, Circulation.

Prospective Study of Pathogen Burden and Risk of Myocardial Infarction or Death

B. Horne, Jeffrey L. Anderson, F. Nieto, 2001, Circulation.

The Development of an Infrastructure to Facilitate the Use of Whole Genome Sequencing for Population Health

Nephi A. Walton, David P. Taylor, K. Stefánsson, 2022, Journal of personalized medicine.

A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Deepak L. Bhatt, M. Sayre, D. DeMets, 2009 .

Short‐Term Exposure to Fine Particulate Matter Air Pollution Is Preferentially Associated With the Risk of ST‐Segment Elevation Acute Coronary Events

C. Pope, B. Horne, Jeffrey L. Anderson, 2015, Journal of the American Heart Association.

2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

M. Link, D. DeMets, Jeffrey L. Anderson, 2012, The Journal of thoracic and cardiovascular surgery.

Smartphone ECG for evaluation of ST-segment elevation myocardial infarction (STEMI): Design of the ST LEUIS International Multicenter Study.

Benjamin Chisum, Brianna S. Ronnow, T. Bunch, 2017, Journal of electrocardiology.

Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.

E. Antman, J. Mega, B. Horne, 2010, JAMA.

ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.

Manesh R. Patel, Richard D. White, S. Kaul, 2010, Circulation.

ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.

Richard D. White, S. Kaul, C. Tracy, 2010, Circulation.

ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities.

J. Ornato, C. Yancy, L. Newby, 2008, Heart rhythm.

ACC/AHA/ESC PRACTICE GUIDELINES ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

J. Ornato, E. Antman, C. Tracy, 2006 .

Foundation/American Heart Association Task Force on Practice Guidelines Asymptomatic Adults : A Report of the American College of Cardiology 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in

M. Budoff, J. Alpert, C. Yancy, 2011 .

2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Mark A Hlatky, David L Hayes, Gabriel Gregoratos, 2013, Circulation.

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Zahi A Fayad, Mark A Hlatky, Joseph S Alpert, 2010, Journal of the American College of Cardiology.

MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION

Sidney C. Smith, G. Mensah, Yuling Hong, 2003 .

Frequency and Outcomes of Patients Presenting with Non-ST Elevation Myocardial Infarction (NSTEMI) without Standard Modifiable Risk Factors: A US Healthcare Experience

H. May, T. Bair, J. Muhlestein, 2023, Journal of clinical medicine.

Cardiovascular Outcomes of ST-Elevation Myocardial Infarction (STEMI) Patients without Standard Modifiable Risk Factors (SMuRF-Less): The Intermountain Healthcare Experience

H. May, T. Bair, J. Muhlestein, 2022, Journal of clinical medicine.

Practice Guidelines College of Cardiology Foundation/American Heart Association Task Force on Atrial Fibrillation (Updating the 2006 Guideline): A Report of the American 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With

M. Ezekowitz, C. January, W. Stevenson, 2011 .

Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score.

H. May, D. Lappé, T. Bair, 2013, Heart rhythm.

ACCF/AHA/SCAI Practice Guideline 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions

G. Levine, S. Ellis, S. Bailey, 2011 .

Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia.

B. Horne, H. May, D. Lappé, 2010, Heart rhythm.

ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).

Timothy J Gardner, J. Ornato, E. Antman, 2004, Circulation.

ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).

J. Ornato, E. Antman, Jeffrey L. Anderson, 2004, Journal of the American College of Cardiology.

2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Hugh Calkins, Brian Olshansky, H. Calkins, 2016, Circulation.

Rapid melting curve analysis for genetic variants that underlie inter-individual variability in stable warfarin dosing

B. Horne, H. May, J. Carlquist, 2008, Journal of Thrombosis and Thrombolysis.

The reduction of inflammatory biomarkers by statin, fibrate, and combination therapy among diabetic patients with mixed dyslipidemia: the DIACOR (Diabetes and Combined Lipid Therapy Regimen) study.

B. Horne, H. May, R. Pearson, 2006, Journal of the American College of Cardiology.

Usefulness of left atrial appendage volume as a predictor of embolic stroke in patients with atrial fibrillation.

B. Horne, Jeffrey L. Anderson, J. Muhlestein, 2013, The American journal of cardiology.

Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia.

H. May, T. Bair, Jeffrey L. Anderson, 2014, Heart rhythm.

Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.

D. DeMets, J. Le Heuzey, M. Ezekowitz, 2013, Circulation.

ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents.

Mario J. Garcia, Deepak L. Bhatt, Jane A. Linderbaum, 2012, Journal of the American College of Cardiology.

ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities.

J. Ornato, C. Yancy, L. Newby, 2008, Heart rhythm.

Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular events

B. Horne, H. May, J. Carlquist, 2023, Frontiers in cardiovascular medicine.

Randomized Secondary Prevention Trial of Azithromycin in Patients With Coronary Artery Disease: Primary Clinical Results of the ACADEMIC Study

B. Horne, J. Carlquist, R. Pearson, 2000, Circulation.

Foundation/American Heart Association Task Force on Practice Guidelines Executive Summary : A Report of the American College of Cardiology 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery:

J. Cigarroa, M. Winniford, O. Selnes, 2012 .

[ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery].

J. Ornato, C. Yancy, L. Fleisher, 2009, Masui. The Japanese journal of anesthesiology.

Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case-control study.

Jeffrey L. Anderson, S. Hunt, P. Hopkins, 2009, Atherosclerosis.

Angiotensin-converting enzyme genotypes and risk for myocardial infarction in women.

J. Carlquist, T. Bair, J. Muhlestein, 1998, Journal of the American College of Cardiology.

Randomized cross-over trial of short-term water-only fasting: metabolic and cardiovascular consequences.

B. Horne, H. May, D. Lappé, 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease.

J. Carlquist, T. Bair, S. P. Elmer, 1999, Journal of the American College of Cardiology.

Subsequent Event Risk in Individuals With Established Coronary Heart Disease

Yan V. Sun, P. Deloukas, T. Lehtimäki, 2019, Circulation. Genomic and precision medicine.

A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine) Writing Committee Members Task Force Members Vogel Ra. Integrating Complementary Medicine

C. Tracy, C. Grines, S. Kaul, 2022 .

A Possible Mechanistic Link Between the CYP2C19 Genotype, the Methadone Metabolite Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidene (EDDP), and Methadone-Induced Corrected QT Interval Prolongation in a Pilot Study

J. Carlquist, L. Webster, John A. Huntinghouse, 2015, Molecular Diagnosis & Therapy.

Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease, and receptor binding of low density lipoproteins.

J. Lalouel, P. Hopkins, R. Ward, 1997, Journal of lipid research.

Genome-Wide Significance and Replication of the Chromosome 12p11.22 Locus Near the PTHLH Gene for Peripartum Cardiomyopathy

B. Horne, H. May, J. Muhlestein, 2011, Circulation. Cardiovascular genetics.

Extreme erythrocyte macrocytic and microcytic percentages are highly predictive of morbidity and mortality.

B. Horne, H. May, J. Muhlestein, 2018, JCI insight.

Both initial red cell distribution width (RDW) and change in RDW during heart failure hospitalization are associated with length of hospital stay and 30‐day outcomes

J. L. Anderson, B. Horne, H. May, 2016, International journal of laboratory hematology.

Association of the Intermountain Risk Score with major adverse health events in patients positive for COVID-19: an observational evaluation of a US cohort

B. Horne, H. May, Brianna S. Ronnow, 2022, BMJ Open.

Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction.

B. Horne, J. Carlquist, S. P. Elmer, 1998, Journal of the American College of Cardiology.

Incremental survival benefit with adherence to standardized heart failure core measures: a performance evaluation study of 2958 patients.

Benjamin D. Horne, Colleen Roberts, Joseph B. Muhlestein, 2008, Journal of cardiac failure.

J. Ornato, E. Antman, J. Alpert, 2004, Circulation.

An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO).

J. Muhlestein, J. Anderson, M. A. Gomez, 1996, Journal of the American College of Cardiology.

Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.

B. Horne, D. Lappé, D. Renlund, 2005, The American journal of cardiology.

Extreme erythrocyte macrocytic and microcytic percentages are highly predictive of morbidity and mortality.

B. Horne, H. May, J. Muhlestein, 2018, JCI insight.

Warfarin Is Not Needed in Low‐Risk Patients Following Atrial Fibrillation Ablation Procedures

H. May, D. Lappé, T. Bair, 2009, Journal of cardiovascular electrophysiology.

Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease.

B. Horne, J. Carlquist, T. Bair, 2000, Journal of the American College of Cardiology.

Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality.

B. Horne, R. Pearson, T. Bair, 2001, The American journal of cardiology.

Propagation and characterization of lymphocytes from rejecting human cardiac allografts.

J. Carlquist, E. Hammond, Jeffrey L. Anderson, 1988, The Journal of heart transplantation.

Secretory Phospholipase A2-IIA and Cardiovascular Disease A Mendelian Randomization Study

Tom R. Gaunt, O. Franco, M. Tobin, 2020 .

Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction.

J. Carlquist, T. Bair, S. P. Elmer, 1999, Journal of the American College of Cardiology.

B. Horne, J. Carlquist, J. Muhlestein, 1999, Circulation.

Comparison of Three Atherosclerotic Cardiovascular Disease Risk Scores With and Without Coronary Calcium for Predicting Revascularization and Major Adverse Coronary Events in Symptomatic Patients Undergoing Positron Emission Tomography-Stress Testing.

B. Horne, D. Lappé, Jeffrey L. Anderson, 2019, The American journal of cardiology.

Comparison of Signal‐Averaging Electrocardiographic Systems Using Device Specific Criteria in 104 Normal Subjects

S. Horn, J. Anderson, L. Karagounis, 1994, Pacing and clinical electrophysiology : PACE.

Chronic infection and coronary artery disease.

J. Muhlestein, Jeffrey L. Anderson, 2003, The Medical clinics of North America.

A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease.

B. Horne, J. Carlquist, R. Pearson, 2000, Journal of the American College of Cardiology.

Randomized Secondary Prevention Trial of Azithromycin in Patients With Coronary Artery Disease: Primary Clinical Results of the ACADEMIC Study

B. Horne, J. Carlquist, R. Pearson, 2000, Circulation.

Spontaneous Variability of Ventricular Ectopic Activity in Patients with Sustained Ventricular Tachycardia and in Survivors of Cardiac Arrest

Jeffrey L. Anderson, J. Mason, M. Anastasiou-Nana, 1998 .

Contemporary Clinical Trials in Ventricular Tachycardia and Fibrillation: Implications of ESVEM, CASCADE, and CASH for Clinical Management

Jeffrey L. Anderson, 1995, Journal of cardiovascular electrophysiology.

Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease.

J. Carlquist, T. Bair, S. P. Elmer, 1999, Journal of the American College of Cardiology.

Lack of association of Helicobacter pylori infection with coronary artery disease and frequency of acute myocardial infarction or death.

B. Horne, Jeffrey L. Anderson, A. Quyyumi, 2002, The American journal of cardiology.

Bethanidine Sulfate in Paroxysmal Ventricular Tachycardia: Toxicity and Antifibrillatory Actions

J. Anderson, J. Bauman, D. Prechel, 1986, Pharmacotherapy.

Short‐Term Exposure to Fine Particulate Matter Air Pollution Is Preferentially Associated With the Risk of ST‐Segment Elevation Acute Coronary Events

C. Pope, B. Horne, J. Muhlestein, 2015, Journal of the American Heart Association.